Jul 16, 2025 8:05 am EDT LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements
Jul 9, 2025 8:05 am EDT New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials
